Laparoscopic/ Robotic: Prostate

Moderated Poster Session

MP15-12 - Preservation of Membranous Urethral Length during Robot-Assisted Radical Prostatectomy Improves Recovery of Early and Long-Term Urinary Zero-pad Continence

Saturday, September 22
10:00 AM - 12:00 PM
Location: Room 242B

Introduction & Objective : To determine impact of surgical preservation of membranous urethral length (MUL)  on early and late 0-pad continence post robot-assisted radical prostatectomy (RARP). 


Methods :

To maximize preservation of MUL we stopped stapling the dorsal venous complex (DVC) early in the dissection.  Now, as the final step of extrication, we transect the DVC without stapling or suturing which allows full rotation of the prostate for circumferential release of apical attachments maximizing MUL. 354 had complete follow-up and were included: 167 prior and 187 MUL group. Outcomes were 0-pad continence at 30-days and 1-year post-RARP. Cox regression was used to model time to continence recovery, after controlling for significant covariates.


Results : Age, BMI, prostate volume, and pre-op IIEF-5 were similar between groups; however, proportion of pre-operative PSA>10 (10.8% vs 30.5%) and pathologic Gleason Score (pGS)>8 (13.8% vs. 23.5%) were higher in the MUL group (p<0.01, respectively). 0-pad continence at 30-days was sharply increased from 20.5% to 55.6% in the MUL group (p<0.001) and 1+year continence was 86.3% and 91.0%, respectively (p=0.167). Age-stratified 30-day and 1-year continence (Table 1) rates highlight substantially higher continence rates in older men (≥ 75 years).

In multivariable regression, MUL was the only significant predictor of 30-day continence (OR=5.101, 95%CI:3.079-8.451), while age (OR=0.938, 95%CI:0.882-0.999) was the only predictor of overall continence. In Cox regression (Figure 1), patients subsequent to technique change had significantly shorter time to continence recovery, after adjusting for pre-op PSA and pGS (p=0.003). 


Conclusions : Maximization of MUL during RARP improves 30-day pad-free continence and time to continence recovery. This benefit encourages maximization of MUL, particularly in effort to improve continence recovery in men ≥ 75.

Thomas E. Ahlering

Professor and Vice Chairman
University of California, Irvine

Dr. Ahlering is a highly regarded surgeon in Urologic cancers. His years of experience in treatment of prostate, bladder, kidney and testicular cancers has placed him as one of the original America's Best Doctors since his membership in 1994. Formerly the Chief of the Division of Urology (1992-2002) after his arrival at UC Irvine from the City of Hope in 1992, Dr. Ahlering became Chief of the Division of Urologic Oncology when the new Department of Urology was established in 2002. He received his medical degree at St. Louis University School of Medicine, followed by a residency in urology at the University of Southern California in Los Angeles and a two-year fellowship in urologic oncology under the clinical training of Dr. Donald G. Skinner and laboratory training under Peter Jones, Ph.D. He has received local, national, and international recognition for his expertise in urologic oncology, particularly in the development of minimally invasive radical prostatectomy assisted by the da Vinci robot. He has performed more than 2000 such robotic surgeries, including the first robotic prostatectomy surgeries in Southern California, Denmark, Australia, and Canada.

Presentation(s):

    Send Email for Thomas Ahlering

    Linda M. Huynh

    Senior Clinical Research Coordinator
    University of California, Irvine

    MSc Biomedical and Translatonal Science
    Senior Clinical Research Coordinator
    University of California, Irvine

    Presentation(s):

      Send Email for Linda Huynh

      Young Hwii Ko

      Associate Professor
      Yeungnam University Hospital

      Presentation(s):

        Send Email for Young Hwii Ko

        Kaelyn See

        Presentation(s):

          Send Email for Kaelyn See

          Whitney Zhang

          Presentation(s):

            Send Email for Whitney Zhang

            Douglas Skarecky

            Presentation(s):

              Send Email for Douglas Skarecky


              Assets

              MP15-12 - Preservation of Membranous Urethral Length during Robot-Assisted Radical Prostatectomy Improves Recovery of Early and Long-Term Urinary Zero-pad Continence



              Attendees who have favorited this

              Please enter your access key

              The asset you are trying to access is locked. Please enter your access key to unlock.

              Send Email for MP15-12 - Preservation of Membranous Urethral Length during Robot-Assisted Radical Prostatectomy Improves Recovery of Early and Long-Term Urinary Zero-pad Continence